Chef Michael Chiarello's Alleged Weight Loss Drug Use Before Passing


Chef Michael Chiarello's Alleged Weight Loss Drug Use Before Passing
© Dave Kotinsky/GettyImages

In the days leading up to the unexpected passing of renowned chef Michael Chiarello, new details have emerged, shedding light on his health and lifestyle choices. The culinary world was left in shock when the former Food Network star died in October at the age of 61.

The tragedy occurred after Chiarello suffered an acute allergic reaction, leading to his hospitalization in Napa, California, as confirmed by Gruppo Chiarello on October 7. While the exact cause of the allergic reaction remains a mystery, with Gruppo Chiarello's representative stating to People magazine that the family and doctors were at a loss, further revelations have surfaced.

The Napa County Coroner's Office, speaking to multiple media outlets, disclosed that anaphylactic shock, resulting from this reaction, led to a fatal heart attack. Interestingly, traces of cocaine were found in Chiarello's system at the time of his death, though officials do not suspect an overdose.

Chiarello's Medication Mystery

The Napa County Sheriff-Coroner's report, obtained by Entertainment Tonight, brings to light more intriguing aspects of Chiarello's life. Eileen, Chiarello's estranged wife, informed authorities that he had mentioned using a new weight loss drug, believed to be Ozempic or a similar medication, primarily used for diabetic patients but recently noted for its weight-loss effects.

She was aware of its injectable nature but unclear on the specifics of its administration. Further deepening the narrative, Kellie, Chiarello's partner, revealed to authorities that he had been taking tirzepatide injections, a treatment for adults with type 2 diabetes, weekly for the last three months.

While the exact date of his last dose remains uncertain, the coroner's report, as per Kellie's account, indicated that he hadn't taken the medication in the fortnight leading up to his hospitalization. On October 5, the day he was admitted to the hospital, Chiarello experienced severe hives and facial swelling, prompting Kellie to administer Benadryl and rush him to the hospital.

Tragically, he ceased breathing en route, leading to an emergency 911 call and his subsequent death the next day. In the wake of this incident, Novo Nordisk, the manufacturer of Ozempic, issued a statement through E! News. Emphasizing patient safety and the importance of supervising the use of their type 2 diabetes drug, especially given its newfound popularity for weight loss among celebrities, the spokesperson underscored the company's commitment to responsible medicine usage.